Alan Wong, founder and lead consultant of Biolaxygen, is a globally recognized leader in biomanufacturing, technical program leadership, and complex supply chain management. With over 30 years of expertise, he has lead and spearheaded innovations at industry giants like Pharmaron, Wuxi Bio, Regeneron, and Biogen-Idec. His leadership has been instrumental in securing FDA and EMA approvals for groundbreaking therapies, including Enbrel, Eylea, and Factor IX—treatments that have transformed patient care worldwide. Alan has received an MBA in Finance from Le Moyne College and a BS in Chemical Engineering from the University of Rochester.
As an Adjunct Professor at the Hong Kong University of Science & Technology, Alan shares his deep industry knowledge with the next generation of biopharma leaders. Renowned for his ability to streamline operations, enhance product quality, and deliver strategic results, Alan is the trusted authority biopharma companies turn to when success is non-negotiable.
"Our mission at Biolaxygen is to empower biopharma professionals to pioneer life-changing solutions, advancing medicine and transforming lives globally."
